Enhertu 100 MG vials

Ended Awarded

Contract number
SPE2DR26F51NT
Awardee
Awarding agency
Obligated
$19,262

Award facts

Contract value 100% obligated
$19,262.40 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $19,262.40 delivery order to Amerisourcebergen Drug Corp on June 3, 2026, for 100 mg vials of ENHERTU (fam-trastuzumab deruxtecan-nxki), an oncology therapeutic, with ultimate completion on June 25, 2026.

Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside. Amerisourcebergen executes pharmaceutical distribution under DLA's Troop Support Medical IDC program, which supplies brand-name and generic medications, specialty pharmaceuticals, and vaccines to Defense Health Agency and military medical facilities globally.

Quick answers

Who was awarded contract SPE2DR26F51NT?

SPE2DR26F51NT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 3, 2026.

How much is contract SPE2DR26F51NT worth?

The government has obligated $19,262 on SPE2DR26F51NT.

Is contract SPE2DR26F51NT an order under another contract?

Yes. SPE2DR26F51NT is a delivery order under SPE2DR25D2101, an indefinite delivery contract.

Was contract SPE2DR26F51NT competed?

The extent of competition for SPE2DR26F51NT was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award